within Pharmacolibrary.Drugs.ATC.A;

model A02BD04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.00025,
    adminDuration  = 600,
    adminMass      = 1540 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A02BD04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>A fixed-dose combination used for eradication of Helicobacter pylori infection and treatment of peptic ulcer disease, comprising a proton pump inhibitor (pantoprazole) and two antibiotics (amoxicillin and clarithromycin). This combination is approved and widely used as standard triple therapy.</p><h4>Pharmacokinetics</h4><p>Estimated population pharmacokinetic parameters for the oral co-administration of pantoprazole 40 mg, amoxicillin 1000 mg, and clarithromycin 500 mg, twice daily in healthy adults, based on available literature of individual components.</p><h4>References</h4><ol><li><p>Ghim, JL, et al., &amp; Shin, JG (2021). Pharmacokinetics and Pharmacodynamics of Tegoprazan Coadministered With Amoxicillin and Clarithromycin in Healthy Subjects. <i>Journal of clinical pharmacology</i> 61(7) 913–922. DOI:<a href=\"https://doi.org/10.1002/jcph.1805\">10.1002/jcph.1805</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33341955/\">https://pubmed.ncbi.nlm.nih.gov/33341955</a></p></li><li><p>Cheer, SM, et al., &amp; Lamb, HM (2003). Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders. <i>Drugs</i> 63(1) 101–133. DOI:<a href=\"https://doi.org/10.2165/00003495-200363010-00006\">10.2165/00003495-200363010-00006</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12487624/\">https://pubmed.ncbi.nlm.nih.gov/12487624</a></p></li><li><p>Pilotto, A, et al., &amp; Valerio, G (2001). Cure of Helicobacter pylori infection in elderly patients: comparison of low versus high doses of clarithromycin in combination with amoxicillin and pantoprazole. <i>Alimentary pharmacology &amp; therapeutics</i> 15(7) 1031–1036. DOI:<a href=\"https://doi.org/10.1046/j.1365-2036.2001.01008.x\">10.1046/j.1365-2036.2001.01008.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11421879/\">https://pubmed.ncbi.nlm.nih.gov/11421879</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A02BD04;
